Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,504 | 500 | 98.3% |
| Education | $179.98 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,465 | 68 | $0 (2024) |
| Janssen Biotech, Inc. | $964.46 | 49 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $784.48 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $742.83 | 34 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $664.29 | 31 | $0 (2024) |
| GENZYME CORPORATION | $614.52 | 28 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $605.27 | 30 | $0 (2024) |
| Amgen Inc. | $598.67 | 19 | $0 (2024) |
| LEO Pharma Inc. | $559.45 | 29 | $0 (2024) |
| Incyte Corporation | $540.46 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,154 | 148 | Janssen Biotech, Inc. ($524.04) |
| 2023 | $2,678 | 130 | Novartis Pharmaceuticals Corporation ($309.08) |
| 2022 | $2,717 | 128 | ABBVIE INC. ($655.60) |
| 2021 | $2,135 | 96 | Ortho Dermatologics, a division of Bausch Health US, LLC ($253.22) |
All Payment Transactions
502 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Oncology | ||||||
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: Immunology | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Sensus Healthcare, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Podiatry | ||||||
| 12/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: Immunology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.27 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Dermatology | ||||||
| 11/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Immunology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: ACNE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,311 | 2,419 | $275,490 | $65,663 |
| 2022 | 19 | 1,348 | 2,554 | $289,731 | $74,809 |
| 2021 | 20 | 1,145 | 2,173 | $244,775 | $63,671 |
| 2020 | 20 | 1,177 | 2,070 | $220,788 | $57,033 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 293 | 430 | $78,260 | $19,543 | 25.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 151 | 180 | $40,680 | $9,929 | 24.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 155 | 193 | $39,951 | $9,213 | 23.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 220 | 292 | $37,084 | $7,063 | 19.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 66 | 119 | $12,495 | $3,413 | 27.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 155 | 865 | $11,245 | $3,238 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $12,934 | $3,179 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 65 | 74 | $8,362 | $2,141 | 25.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 19 | $6,232 | $1,875 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 22 | $5,720 | $1,534 | 26.8% |
| 69100 | Biopsy of ear | Office | 2023 | 21 | 25 | $4,900 | $864.78 | 17.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 17 | $4,386 | $851.95 | 19.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 18 | 34 | $3,808 | $846.24 | 22.2% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 14 | $3,458 | $799.29 | 23.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $3,335 | $764.15 | 22.9% |
| 11300 | Shaving of skin growth of body, arms, or legs, 0.5 cm or less | Office | 2023 | 11 | 12 | $2,472 | $374.52 | 15.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 42 | $168.00 | $34.28 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 303 | 437 | $79,534 | $21,127 | 26.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 145 | 175 | $39,550 | $10,457 | 26.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 136 | 167 | $34,569 | $8,332 | 24.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 205 | 283 | $35,941 | $7,323 | 20.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 62 | 125 | $13,125 | $4,056 | 30.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 69 | 69 | $15,387 | $3,696 | 24.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 155 | 917 | $11,921 | $3,599 | 30.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 81 | 102 | $11,526 | $3,177 | 27.6% |
About Brenda Sanchez, NP
Brenda Sanchez, NP is a Family healthcare provider based in Spring Hill, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1467806638.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brenda Sanchez, NP has received a total of $10,684 in payments from pharmaceutical and medical device companies, with $3,154 received in 2024. These payments were reported across 502 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($10,504).
As a Medicare-enrolled provider, Sanchez has provided services to 4,981 Medicare beneficiaries, totaling 9,216 services with total Medicare billing of $261,177. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Spring Hill, TN
- Active Since 04/14/2016
- Last Updated 04/14/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1467806638
Products in Payments
- DUPIXENT (Biological) $1,288
- TREMFYA (Drug) $897.52
- SKYRIZI (Biological) $604.43
- RINVOQ (Biological) $600.79
- OPZELURA (Drug) $540.46
- ADBRY (Biological) $538.33
- Otezla (Drug) $470.37
- Sotyktu (Drug) $459.08
- COSENTYX (Drug) $425.61
- EUCRISA (Drug) $362.00
- TALTZ (Drug) $347.25
- ILUMYA (Biological) $294.81
- JUBLIA (Drug) $290.23
- HUMIRA (Biological) $259.71
- ARAZLO (Drug) $258.18
- Zoryve (Drug) $214.92
- Puraply (Medical Supply) $192.67
- Cimzia (Drug) $188.96
- AKLIEF (Drug) $150.87
- Winlevi (Drug) $144.23
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Spring Hill
Jessica Adams
Family — Payments: $7,899
Ms. Ann-Marie Davidson, Aprn, APRN
Family — Payments: $5,683
Ms. Samia Boufares, Aprn, APRN
Family — Payments: $4,743
Kelly Odum, Fnp-C, FNP-C
Family — Payments: $4,058
Laura Murff, Fnp, FNP
Family — Payments: $3,881
Jennifer Conran, Aprn, APRN
Family — Payments: $3,554